Registration No. 333-        

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Scientific-Atlanta, Inc.

(Exact name of Registrant as Specified in Its Charter)

Georgia	58-0612397
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

5030 Sugarloaf Parkway, Lawrenceville Georgia	30044-2689
(Address of Principal Executive Offices)	(Zip Code)

2003 Long-Term Incentive Plan of Scientific-Atlanta, Inc.

(Full Title of the Plan)

James F. McDonald

President, Chief Executive Officer and Chairman of the Board

Scientific-Atlanta, Inc.

5030 Sugarloaf Parkway

Lawrenceville, Georgia 30044-2689

(Name and Address of Agent For Service)

(770) 236-5000

(Telephone Number, Including Area Code, of Agent For Service)

Please address a copy of all communications to:

Michael C. Veysey, Esq.

Senior Vice President, General Counsel and Corporate Secretary

Scientific-Atlanta, Inc.

5030 Sugarloaf Parkway

Lawrenceville, Georgia 30044-2689

(770) 236-5000

CALCULATION OF REGISTRATION FEE

Title of Securities To Be Registered	Amount To Be Registered (1)	Proposed Maximum Offering Price Per Share (2)		Proposed Maximum Aggregate Offering Price		Amount Of Registration Fee
Common Stock, par value $0.50 per share, together with associated preferred stock purchase rights (3)	8,000,000 shares	$	32.72	$	261,760,000	$	33,165

(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement covers an indeterminate number of additional shares which may be offered and issued to prevent dilution resulting from stock dividends or similar transactions as provided in the 2003 Long-Term Incentive Plan of Scientific-Atlanta, Inc.

(2) Calculated pursuant to Rules 457(c) and 457(h)(1), based on the average of the per share high and low closing sale prices ($33.05 and $32.39, respectively) of the common stock of the registrant on the New York Stock Exchange on February 5, 2004.

(3) The securities also include preferred stock purchase rights associated with the common stock. These preferred stock purchase rights cannot trade separately from the underlying common stock and, therefore, do not carry a separate price or necessitate a separate filing.

PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1. Plan Information.*

Item 2. Registrant Information and Employee Plan Annual Information.*

* Information required by Part I to be contained in the Section 10(a) prospectus is omitted from the Registration Statement in accordance with Rule 428 under the Securities Act of 1933, as amended, and the Note to Part I of Form S-8.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents are incorporated herein by reference:

(a) Scientific-Atlanta’s Annual Report on Form 10-K for the year ended June 27, 2003;

(b) Scientific-Atlanta’s Current Report on Form 8-K dated July 17, 2003;

(c) Scientific-Atlanta’s Quarterly Report on Form 10-Q for the quarter ended October 3, 2003;

(d) Scientific-Atlanta’s Current Report on Form 8-K dated October 23, 2003;

(e) Scientific-Atlanta’s Quarterly Report on Form 10-Q for the quarter ended January 2, 2004;

(f) Scientific-Atlanta’s Current Report on Form 8-K dated January 22, 2004;

(g) All other reports filed pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, since the end of the fiscal year covered by the Scientific-Atlanta’s annual report referred to in (a) above; and

(h) The description of Scientific-Atlanta’s common stock, par value $0.50 per share, which is contained in its registration statement on Form 10 filed under Section 12 of the Exchange Act, and the description of the rights to purchase preferred stock, which is contained in its registration statement on Form 8-A filed under Section 12 of the Exchange Act, including any amendments or reports filed for the purposes of updating such descriptions.

All documents subsequently filed with the Securities and Exchange Commission by Scientific-Atlanta pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment to this registration statement which indicates that all

2

securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing such documents.

Item 4. Description of Securities.

Not applicable.

Item 5. Interests of Named Experts and Counsel.

Not applicable.

Item 6. Indemnification of Directors and Officers.

Sections 14-2-850 through 14-2-859 of the Georgia Business Corporation Code provide for the indemnification of officers and directors under certain circumstances against reasonable expenses incurred in defending against a claim and authorizes Georgia corporations to indemnify their officers and directors under certain circumstances against reasonable expenses and liabilities incurred in legal proceedings involving such persons because of their being or having been an officer or director.

Article VII of the By-laws of Scientific-Atlanta (filed as Exhibit 3 to Scientific-Atlanta’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 27, 2002) permits indemnification by Scientific-Atlanta of its officers and directors to the full extent authorized by the Georgia Business Corporation Code. In addition, Scientific-Atlanta has entered into indemnification agreements (forms of which are filed as Exhibits 10.19.1 and 10.19.2 to Scientific-Atlanta’s Annual Report on Form 10-Q for the fiscal year ended June 27, 2003) with each of its directors and certain of its officers that provide these directors and officers with the indemnification by the Company described above and assure these directors and officers that such indemnification will continue to be provided despite future changes in the By-laws of the Company. The Company also provides insurance coverage pursuant to which officers and directors are indemnified or insured against liability or loss under certain circumstances, which may include liability or related loss under the Securities Act and the Exchange Act.

Item 7. Exemption from Registration Claimed.

Not applicable.

Item 8. Exhibits.

The exhibits filed as part of this registration statement are as follows:

Exhibit Number	Description of Exhibit
5	Opinion of Michael C. Veysey, General Counsel of Scientific-Atlanta, as to the legality of the securities being registered.
23.1	Consent of Michael C. Veysey (contained in Exhibit 5).
23.2	Consent of Ernst & Young LLP.

3

Item 9. Undertakings.

The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

4

SIGNATURES

The Registrant. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Lawrenceville, state of Georgia, on this 12^th day of February, 2004.

SCIENTIFIC-ATLANTA, INC.
By:	/s/ James F. McDonald
	Name: James F. McDonald
	Title: President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Name	Title
/s/ James F. McDonald James F. McDonald	President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)
Date: February 8, 2004
/s/ Julian W. Eidson Julian W. Eidson	Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)
Date: February 8, 2004
/s/ Steven D. Boyd Steven D. Boyd	Vice President and Controller (Principal Accounting Officer)
Date: February 8, 2004

5

/s/ Marion H. Antonini Marion H. Antonini, Director	February 12, 2004 Date
/s/ James I. Cash, Jr. James I. Cash, Jr., Director	February 12, 2004 Date
/s/ David W. Dorman David W. Dorman, Director	February 12, 2004 Date
/s/ William E. Kassling William E. Kassling, Director	February 12, 2004 Date
/s/ Mylle H. Mangum Mylle H. Mangum, Director	February 12, 2004 Date
/s/ Terence F. McGuirk Terence F. McGuirk, Director	February 12, 2004 Date
/s/ David J. McLaughlin David J. McLaughlin, Director	February 12, 2004 Date
/s/ James V. Napier James V. Napier, Director	February 12, 2004 Date
/s/ Sam Nunn Sam Nunn, Director	February 12, 2004 Date

6

EXHIBIT INDEX

Exhibit Number	Description of Exhibit
5	Opinion of Michael C. Veysey, General Counsel of Scientific-Atlanta, as to the legality of the securities being registered.
23.1	Consent of Michael C. Veysey (contained in Exhibit 5).
23.2	Consent of Ernst & Young LLP.